Person—diabetes therapy type, code NN
Data Element Attributes
Identifying and definitional attributes | |
Metadata item type:![]() | Data Element |
---|---|
Short name:![]() | Diabetes therapy type |
METEOR identifier:![]() | 270236 |
Registration status:![]() | Health, Standard 01/03/2005 |
Definition:![]() | The type of diabetes therapy the person is currently receiving, as represented by a code. |
Data Element Concept:![]() | Person—diabetes therapy type |
Value Domain:![]() | Diabetes therapy code NN |
Data element attributes | |
Collection and usage attributes | |
Collection methods:![]() | To be collected at the commencement of treatment and at each review. |
---|---|
Comments:![]() | In settings where the monitoring of a person's health is ongoing and where management can change over time (such as general practice), the Service contact—service contact date, DDMMYYYY should be recorded. The main use of this data element is to enable categorisation of management regimes against best practice for diabetes. |
Source and reference attributes | |
Submitting organisation:![]() | National Diabetes Data Working Group Cardiovascular Data Working Group |
Reference documents:![]() | Berkow R, editor. The Merck Manual. 16th ed. Rahway (New Jersey, USA): Merck Research Laboratories; 1992. |
Relational attributes | |
Related metadata references:![]() | Is re-engineered from ![]() No registration status See also Female—type of diabetes mellitus therapy during pregnancy, code N Health, Superseded 09/09/2022 See also Female—type of diabetes mellitus therapy during pregnancy, code N Health, Superseded 20/11/2019 See also Female—type of diabetes mellitus therapy during pregnancy, code N Health, Superseded 02/08/2017 See also Female—type of diabetes mellitus therapy during pregnancy, code N Health, Superseded 12/12/2018 See also Female—type of diabetes mellitus therapy during pregnancy, code N Health, Standard 09/09/2022 |
Implementation in Data Set Specifications:![]() | Acute coronary syndrome (clinical) DSS Health, Superseded 01/09/2012 Acute coronary syndrome (clinical) DSS Health, Superseded 02/05/2013 Acute coronary syndrome (clinical) NBPDS 2013- Health, Standard 02/05/2013 Implementation start date: 01/07/2013 Cardiovascular disease (clinical) DSS Health, Superseded 15/02/2006 Cardiovascular disease (clinical) DSS Health, Superseded 04/07/2007 Cardiovascular disease (clinical) DSS Health, Superseded 22/12/2009 Cardiovascular disease (clinical) DSS Health, Superseded 01/09/2012 Cardiovascular disease (clinical) NBPDS Health, Superseded 17/10/2018 Cardiovascular disease (clinical) NBPDS Health, Standard 17/10/2018 Diabetes (clinical) DSS Health, Superseded 21/09/2005 DSS specific information: The objectives and priorities of treatment must be tailored to the individual considering age, sex, weight and individual health status. An individual management plan for each patient should include the following:
In addition to glycaemic control, management of diabetes of either type requires close attention to other risk factors for the development of complications, and the impact of lifestyle changes on blood glucose levels should be monitored. In patients with Type 2 diabetes, an increase in physical activity is essential in management of lipids and glucose level. Increased physical activity has been recognised as perhaps the most feasible way of modifying glucose intolerance, a risk factor for developing diabetes and macrovascular disease (Guest & O'Dea 1992). Diabetes (clinical) NBPDS Health, Standard 21/09/2005 DSS specific information: The objectives and priorities of treatment must be tailored to the individual considering age, sex, weight and individual health status. An individual management plan for each patient should include the following:
In addition to glycaemic control, management of diabetes of either type requires close attention to other risk factors for the development of complications, and the impact of lifestyle changes on blood glucose levels should be monitored. In patients with Type 2 diabetes, an increase in physical activity is essential in management of lipids and glucose level. Increased physical activity has been recognised as perhaps the most feasible way of modifying glucose intolerance, a risk factor for developing diabetes and macrovascular disease (Guest & O'Dea 1992). |